Report Detail
Global (United States, European Union and China) Hereditary Angioedema Market Research Report 2019-2025
- RnM3573909 |
- 19 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
In 2019, the market size of Hereditary Angioedema is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hereditary Angioedema.
This report studies the global market size of Hereditary Angioedema, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hereditary Angioedema sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
...
Market Segment by Product Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Hereditary Angioedema status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hereditary Angioedema manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Hereditary Angioedema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Hereditary Angioedema Market Size Growth Rate by Type (2019-2025)
- 1.3.2 C1 Esterase Inhibitor
- 1.3.3 Kallikrein Inhibitor
- 1.3.4 Selective Bradykinin B2 Receptor Antagonist
- 1.4 Market Segment by Application
- 1.4.1 Global Hereditary Angioedema Market Share by Application (2019-2025)
- 1.4.2 Retail Pharmacies
- 1.4.3 Hospital Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Hereditary Angioedema Market Size
- 2.1.1 Global Hereditary Angioedema Revenue 2014-2025
- 2.1.2 Global Hereditary Angioedema Sales 2014-2025
- 2.2 Hereditary Angioedema Growth Rate by Regions
- 2.2.1 Global Hereditary Angioedema Sales by Regions 2014-2019
- 2.2.2 Global Hereditary Angioedema Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Hereditary Angioedema Sales by Manufacturers
- 3.1.1 Hereditary Angioedema Sales by Manufacturers 2014-2019
- 3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Hereditary Angioedema Revenue by Manufacturers (2014-2019)
- 3.2.2 Hereditary Angioedema Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI)
- 3.3 Hereditary Angioedema Price by Manufacturers
- 3.4 Key Manufacturers Hereditary Angioedema Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Hereditary Angioedema Market
- 3.6 Key Manufacturers Hereditary Angioedema Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 C1 Esterase Inhibitor Sales and Revenue (2014-2019)
- 4.1.2 Kallikrein Inhibitor Sales and Revenue (2014-2019)
- 4.1.3 Selective Bradykinin B2 Receptor Antagonist Sales and Revenue (2014-2019)
- 4.2 Global Hereditary Angioedema Sales Market Share by Type
- 4.3 Global Hereditary Angioedema Revenue Market Share by Type
- 4.4 Hereditary Angioedema Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Hereditary Angioedema Sales by Application
6 United States
- 6.1 United States Hereditary Angioedema Breakdown Data by Company
- 6.2 United States Hereditary Angioedema Breakdown Data by Type
- 6.3 United States Hereditary Angioedema Breakdown Data by Application
7 European Union
- 7.1 European Union Hereditary Angioedema Breakdown Data by Company
- 7.2 European Union Hereditary Angioedema Breakdown Data by Type
- 7.3 European Union Hereditary Angioedema Breakdown Data by Application
8 China
- 8.1 China Hereditary Angioedema Breakdown Data by Company
- 8.2 China Hereditary Angioedema Breakdown Data by Type
- 8.3 China Hereditary Angioedema Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Hereditary Angioedema Breakdown Data by Company
- 9.2 Rest of World Hereditary Angioedema Breakdown Data by Type
- 9.3 Rest of World Hereditary Angioedema Breakdown Data by Application
- 9.4 Rest of World Hereditary Angioedema Breakdown Data by Countries
- 9.4.1 Rest of World Hereditary Angioedema Sales by Countries
- 9.4.2 Rest of World Hereditary Angioedema Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pharming Group NV
- 10.1.1 Pharming Group NV Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.1.4 Hereditary Angioedema Product Introduction
- 10.1.5 Pharming Group NV Recent Development
- 10.2 Shire plc
- 10.2.1 Shire plc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.2.4 Hereditary Angioedema Product Introduction
- 10.2.5 Shire plc Recent Development
- 10.3 CSL Limited
- 10.3.1 CSL Limited Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.3.4 Hereditary Angioedema Product Introduction
- 10.3.5 CSL Limited Recent Development
- 10.4 iBio Inc.
- 10.4.1 iBio Inc. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.4.4 Hereditary Angioedema Product Introduction
- 10.4.5 iBio Inc. Recent Development
- 10.5 BioCryst Pharmaceuticals, Inc.
- 10.5.1 BioCryst Pharmaceuticals, Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.5.4 Hereditary Angioedema Product Introduction
- 10.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
- 10.6 Ionis Pharmaceuticals, Inc.
- 10.6.1 Ionis Pharmaceuticals, Inc. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Hereditary Angioedema
- 10.6.4 Hereditary Angioedema Product Introduction
- 10.6.5 Ionis Pharmaceuticals, Inc. Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Hereditary Angioedema Sales Channels
- 11.2.2 Hereditary Angioedema Distributors
- 11.3 Hereditary Angioedema Customers
12 Market Forecast
- 12.1 Global Hereditary Angioedema Sales and Revenue Forecast 2019-2025
- 12.2 Global Hereditary Angioedema Sales Forecast by Type
- 12.3 Global Hereditary Angioedema Sales Forecast by Application
- 12.4 Hereditary Angioedema Forecast by Regions
- 12.4.1 Global Hereditary Angioedema Sales Forecast by Regions 2019-2025
- 12.4.2 Global Hereditary Angioedema Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Hereditary Angioedema . Industry analysis & Market Report on Hereditary Angioedema is a syndicated market report, published as Global (United States, European Union and China) Hereditary Angioedema Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Hereditary Angioedema market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
